Skip to main content
. 2015 Sep 24;18(3):271–278. doi: 10.4048/jbc.2015.18.3.271

Table 2. Factors associated with use of adjuvant chemotherapy.

Factor Adjuvant chemotherapy (n=3,481)
No. (%)
None (n=549)
No. (%)
Univariate analysis Multivariate analysis
p-value Exp(B) 95% CI p-value
Lower Upper
Age (yr) < 0.001
 ≤ 50 2,189 (89.9) 247 (45.0)
 > 50 1,292 (81.2) 300 (54.6) 0.556 0.434 1.713 < 0.001
 Unknown 2 (0.4)
T stage < 0.001
 T1 1,728 (79.9) 435 (20.1)
 T2 1,756 (93.9) 114 (6.1) 3.166 2.371 4.228 < 0.001
Histologic grade < 0.001
 I 141 (25.9) 57 (28.8)
 II 795 (82.5) 169 (17.5) 1.959 1.317 2.915 0.001
 III 2,125 (92.4) 175 (7.6) 4.428 2.981 6.577 < 0.001
 Unknown 423 (74.1) 148 (25.9)
LVI < 0.001
 No 2,264 (85.7) 377 (14.3)
 Yes 548 (92.7) 43 (7.3) 1.534 1.057 2.227 0.024
 Unknown 672 (83.9) 129 (16.1)
Operation <0.001
 Mastectomy 1,403 (83.8) 271 (16.2)
 BCS 2,057 (88.2) 275 (11.8) 1.385 1.074 1.787 0.012
 Unknown 24 (88.9) 3 (0.5)

CI=confidence interval; LVI=lymphovascular invasion; BCS=breast-conserving surgery.